1. Home
  2. RGLS vs UNB Comparison

RGLS vs UNB Comparison

Compare RGLS & UNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGLS
  • UNB
  • Stock Information
  • Founded
  • RGLS 2007
  • UNB 1891
  • Country
  • RGLS United States
  • UNB United States
  • Employees
  • RGLS N/A
  • UNB N/A
  • Industry
  • RGLS Biotechnology: Pharmaceutical Preparations
  • UNB Major Banks
  • Sector
  • RGLS Health Care
  • UNB Finance
  • Exchange
  • RGLS Nasdaq
  • UNB Nasdaq
  • Market Cap
  • RGLS 106.7M
  • UNB 120.8M
  • IPO Year
  • RGLS 2012
  • UNB 1998
  • Fundamental
  • Price
  • RGLS $1.48
  • UNB $27.05
  • Analyst Decision
  • RGLS Strong Buy
  • UNB
  • Analyst Count
  • RGLS 6
  • UNB 0
  • Target Price
  • RGLS $10.33
  • UNB N/A
  • AVG Volume (30 Days)
  • RGLS 263.0K
  • UNB 3.9K
  • Earning Date
  • RGLS 11-07-2024
  • UNB 10-16-2024
  • Dividend Yield
  • RGLS N/A
  • UNB 5.32%
  • EPS Growth
  • RGLS N/A
  • UNB N/A
  • EPS
  • RGLS N/A
  • UNB 2.20
  • Revenue
  • RGLS N/A
  • UNB $47,529,000.00
  • Revenue This Year
  • RGLS N/A
  • UNB N/A
  • Revenue Next Year
  • RGLS N/A
  • UNB N/A
  • P/E Ratio
  • RGLS N/A
  • UNB $12.50
  • Revenue Growth
  • RGLS N/A
  • UNB N/A
  • 52 Week Low
  • RGLS $1.08
  • UNB $21.00
  • 52 Week High
  • RGLS $3.79
  • UNB $32.00
  • Technical
  • Relative Strength Index (RSI)
  • RGLS 44.54
  • UNB 54.38
  • Support Level
  • RGLS $1.47
  • UNB $26.62
  • Resistance Level
  • RGLS $1.65
  • UNB $26.99
  • Average True Range (ATR)
  • RGLS 0.11
  • UNB 0.66
  • MACD
  • RGLS -0.00
  • UNB 0.09
  • Stochastic Oscillator
  • RGLS 15.79
  • UNB 71.92

About RGLS Regulus Therapeutics Inc.

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.

About UNB Union Bankshares Inc.

Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The company provides retail banking services to individuals and commercial banking services to small and medium-sized corporations, partnerships, and sole proprietorships, as well as nonprofit organizations, local municipalities, and school districts within its market area. In addition, it also offers fiduciary and asset management services through its Asset Management Group. Geographically, all the business activity is functioned through the United States.

Share on Social Networks: